Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.56 |
| ▸ | PPARG | P37231 | 7/20 | 0.56 |
| ▸ | PPARD | Q03181 | 7/20 | 0.56 |
| ▸ | PPARA | Q07869 | 7/20 | 0.56 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.56 |
| ▸ | TSHR | P16473 | 4/20 | 0.56 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | TLR2 | O60603 | 2/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | FABP4 | P15090 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.56 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | ESR1 | P03372 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | PDE4A | P27815 | 1/20 | 0.56 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8643046 | 1.00 | GPR84 (0.56) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL10420858 | 1.00 | GPR84 (0.56) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL527256 | 1.00 | GPR84 (0.56) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL14566020 | 1.00 | GPR84 (0.56) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL31273343 | 1.00 | GPR84 (0.56) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL10511281 | 0.92 | GPR84 (0.52) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL10787440 | 0.92 | AKR1B1 (0.50) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL6708723 | 0.92 | CA12 (0.50) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL10727061 | 0.92 | CA12 (0.50) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL10727436 | 0.92 | CA12 (0.50) | GPR84PPARGPPARDPPARAHDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4676446-A1 | NOVEL LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS | CureVac SE (DE) | 2026-01-14 | — | — | EP | disclosed |
| WO-2025132122-A1 | METHODS OF DELIVERING THERAPEUTICS USING LIPID NANOPARTICLES | BERLIN INSTITUTE OF HEALTH (DE) | 2025-06-26 | — | — | WO | disclosed |
| WO-2025106806-A1 | PEGYLATED LIPIDS | Acuitas Therapeutics, Inc. (CA) | 2025-05-22 | — | — | WO | disclosed |
| US-20250161227-A1 | PEGYLATED LIPIDS | Acuitas Therapeutics, Inc. (CA) | 2025-05-22 | — | — | US | disclosed |
| WO-2024184500-A1 | NOVEL LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS | CureVac SE (DE) | 2024-09-12 | — | — | WO | disclosed |
| CN-114685784-A | Poly (2-oxazoline) lipid and lipid nanoparticle for nucleic acid delivery and application | 北京清科胜因生物科技有限公司 | 2022-07-01 | — | — | CN | disclosed |
| US-6812218-B2 | TRANSFERRING NUCLEIC ACIDS TO CELLS | GENCELL S.A. (FR) | 2004-11-02 | — | — | US | disclosed |
| US-20030065033-A1 | Lipid derivatives of polythiourea | GENCELL S.A. (FR) | 2003-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030065033-A1 | Lipid derivatives of polythiourea | ABCB4, TENT4A, PEBP1 | GPR84 1591/4885PPARG 1258/4885PPARD 1202/4885 |
| US-20250161227-A1 | PEGYLATED LIPIDS | PHOSPHO1, SGMS1, SGMS2 | GPR84 3711/4885PPARG 2295/4885PPARD 2890/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.